Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
$7.44
+0.9%
$7.21
$6.05
$8.56
$765.80M1.15672,059 shs432,149 shs
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
C$5.38
+0.9%
C$5.36
C$2.94
C$7.45
C$633.98M1.71327,222 shs311,272 shs
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$11.09
+0.7%
$10.57
$6.70
$11.49
$2.51B0.811.16 million shs713,112 shs
Pharmerica Co. stock logo
PMC
Pharmerica
$0.00
$22.00
$29.50
N/AN/A283,015 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
0.00%+0.28%-1.64%+1.55%-2.17%
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
+0.19%+11.74%-5.50%-2.02%-28.36%
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
-0.23%+1.90%-0.63%+15.41%+38.14%
Pharmerica Co. stock logo
PMC
Pharmerica
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
N/AN/AN/AN/AN/AN/AN/AN/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
2.0747 of 5 stars
3.53.00.00.01.92.50.0
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
N/AN/AN/AN/A
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
N/AN/AN/AN/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
3.00
Buy$14.0026.24% Upside
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/A

Current Analyst Ratings

Latest CRF, PMC, MIR, DFN, and NAIT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/8/2024
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
2/15/2024
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $13.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
N/AN/AN/AN/AN/AN/A
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
C$-22.03M-28.78C$12.56 per share0.43C$4.64 per share1.16
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$800.90M3.13$0.96 per share11.59$6.86 per share1.62
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
-C$114.27M-C$0.98N/AN/AN/A-18.90%-1.35%N/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
-$96.90M-$0.50N/AN/A-12.01%3.09%1.78%4/30/2024 (Confirmed)
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest CRF, PMC, MIR, DFN, and NAIT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
N/AN/AN/AN/AN/AN/A  
2/13/2024Q4 2023
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
N/A$0.12+$0.12$0.32N/A$230.40 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
$1.3518.15%-13.24%N/AN/A
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
C$1.2022.30%N/AN/A N/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
N/AN/AN/AN/AN/A
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/A

Latest CRF, PMC, MIR, DFN, and NAIT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2024
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
monthly$0.103717.5%6/14/20246/14/20246/28/2024
2/14/2024
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
monthly$0.103717.5%6/14/20246/14/20246/28/2024
2/12/2024
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
monthly$0.103717.3%5/14/20245/15/20245/31/2024
4/29/2024
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
MonthlyC$0.1022.51%4/29/20245/10/20245/10/2024
3/27/2024
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
MonthlyC$0.1021.28%3/27/20244/10/20244/10/2024
1/30/2024
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
MonthlyC$0.1022.06%1/30/20242/9/20242/9/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
N/AN/AN/A
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
215.33
1.45
1.75
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
0.44
2.03
1.48
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
10.41%
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
N/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
78.51%
Pharmerica Co. stock logo
PMC
Pharmerica
89.97%

Insider Ownership

CompanyInsider Ownership
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
12.22%
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
N/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
2.57%
Pharmerica Co. stock logo
PMC
Pharmerica
5.04%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cornerstone Total Return Fund, Inc. stock logo
CRF
Cornerstone Total Return Fund
N/A102.93 million90.35 millionNot Optionable
Dividend 15 Split Corp. stock logo
DFN
Dividend 15 Split
N/A117.84 millionN/ANot Optionable
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
3,000226.06 million220.25 millionOptionable
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/ANot Optionable

CRF, PMC, MIR, DFN, and NAIT Headlines

SourceHeadline
Medicine shortage hits TB elimination programme in PuneMedicine shortage hits TB elimination programme in Pune
msn.com - March 30 at 4:53 PM
From next month, PMC hospitals, maternity homes to get generic medicine storesFrom next month, PMC hospitals, maternity homes to get generic medicine stores
msn.com - November 22 at 6:36 AM
Davenport Extreme Pools & Spas owner and spouse charged with fraud, theftDavenport Extreme Pools & Spas owner and spouse charged with fraud, theft
bizjournals.com - October 6 at 6:03 PM
PMC Prodigy 1 reviewPMC Prodigy 1 review
whathifi.com - September 14 at 10:50 PM
Pharmerica Stock Falls On Unusually High Volume (PMC)Pharmerica Stock Falls On Unusually High Volume (PMC)
thestreet.com - May 25 at 8:22 AM
Top Stories: Patient information exposed in PharMerica breachTop Stories: Patient information exposed in PharMerica breach
healthcarefinancenews.com - May 24 at 8:39 PM
PharMerica Notifies 5.8M Individuals of Healthcare Data BreachPharMerica Notifies 5.8M Individuals of Healthcare Data Breach
healthitsecurity.com - May 19 at 12:25 PM
Activities of Daily Living for SeniorsActivities of Daily Living for Seniors
health.usnews.com - April 20 at 2:20 AM
We can howl about staffing challenges, or start fixing themWe can howl about staffing challenges, or start fixing them
mcknights.com - April 18 at 12:13 AM
PAC Profile: Pharmerica CorpPAC Profile: Pharmerica Corp
opensecrets.org - April 18 at 12:13 AM
Golden LivingGolden Living
forbes.com - February 24 at 12:56 AM
Gas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028Gas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028
marketwatch.com - January 17 at 9:51 AM
Kentucky orthopedic practice to relocateKentucky orthopedic practice to relocate
beckersspine.com - December 27 at 2:02 PM
Gas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028Gas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028
marketwatch.com - November 10 at 9:28 PM
9 Medford Residents To Participate In 2022 Pan-Mass Challenge9 Medford Residents To Participate In 2022 Pan-Mass Challenge
msn.com - July 15 at 3:50 PM
Zero tolerance policy on irregularities in medical education system: PMCZero tolerance policy on irregularities in medical education system: PMC
app.com.pk - June 25 at 1:10 PM
PMC among nation’s top-performing hospitals for treatment of heart attack patientsPMC among nation’s top-performing hospitals for treatment of heart attack patients
news-expressky.com - May 25 at 7:28 PM
CVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7BCVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7B
thestreet.com - January 21 at 8:53 PM
View | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiouslyView | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiously
msn.com - December 8 at 1:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cornerstone Total Return Fund logo

Cornerstone Total Return Fund

NYSEAMERICAN:CRF
Cornerstone Total Return Fund, Inc. is a closed-ended equity mutual fund launched and managed by Cornerstone Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value and growth stocks of companies across all market capitalizations. The fund also invests through other closed-end investment companies and ETFs. It benchmarks the performance of its portfolio against the S&P 500 Index. Cornerstone Total Return Fund, Inc. was formed on March 16, 1973 and is domiciled in the United States.
Dividend 15 Split logo

Dividend 15 Split

TSE:DFN
Dividend 15 Split Corp. is a close ended equity mutual fund launched by Quadravest Inc. The fund is managed by Quadravest Capital Management. It invests in public equity markets of Canada. The fund spreads its investments across diversified sectors. It benchmarks the performance of its portfolio against the S&P TSX 60 Index. Dividend 15 Split Corp. was formed on January 9, 2004 and is domiciled in Canada.
Mirion Technologies logo

Mirion Technologies

NYSE:MIR
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Pharmerica logo

Pharmerica

NYSE:PMC
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.